Letrozole therapy, in follow-up to 5 years of tamoxifen treatment, significantly improves disease-free survival compared to placebo, according to a study published in The New England Journal of Medicine.

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

As post-tamoxifen therapy, letrozole cuts breast cancer recurrence 43%

Newsletter